Jan 14, 2025, 09:30
Exploring pharmacogenetic testing for DPD deficiency – FDA Oncology
FDA Oncology posted on X:
“FDA Oncology Center’s Jennifer Gao and AACR President Patricia M. LoRusso will moderate an FDA-AACR workshop Jan. 16 exploring the considerations surrounding pharmacogenetic testing for dihydropyrimidine dehydrogenase (DPD) deficiency.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 21, 2025, 04:17
Jan 20, 2025, 20:33
Jan 20, 2025, 20:31
Jan 20, 2025, 20:26
Jan 20, 2025, 20:21
Jan 20, 2025, 20:12
Jan 20, 2025, 20:10
Jan 20, 2025, 20:08
Jan 20, 2025, 20:06